Press Release
7 May 2025
Backing Secured to Prepare First Trial of Implanted Electric Field Therapy
QV Bioelectronics, developer of a first-in-class implanted Electric Field Therapy (EFT) device for brain tumours, has been awarded a £1.26 million grant under the highly…
12 March 2025
Carl Daintree Joins QV Bioelectronics as COO
Welcoming Carl to QV Bioelectronics! We’re excited to welcome Carl Daintree to the QV Bioelectronics team as the new COO! Carl has deep cross-functional experience,…
Interested in Receiving our Press Releases?
Join our Mailing List
{form}